Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck.

por Thyss, A., Schneider, M., Santini, J., Caldani, C., Vallicioni, J., Chauvel, P., Demard, F.
Publicado 1986

5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer.

por Santini, J., Milano, G., Thyss, A., Renee, N., Viens, P., Ayela, P., Schneider, M., Demard, F.
Publicado 1989

Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status

por Hofman, P, Butori, C, Havet, K, Hofman, V, Selva, E, Guevara, N, Santini, J, Van Obberghen-Schilling, E
Publicado 2008

Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.

por Etienne, M. C., Bernard, S., Fischel, J. L., Formento, P., Gioanni, J., Santini, J., Demard, F., Schneider, M., Milano, G.
Publicado 1991

SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals

por Lam, S. D., Bordin, N., Waman, V. P., Scholes, H. M., Ashford, P., Sen, N., van Dorp, L., Rauer, C., Dawson, N. L., Pang, C. S. M., Abbasian, M., Sillitoe, I., Edwards, S. J. L., Fraternali, F., Lees, J. G., Santini, J. M., Orengo, C. A.
Publicado 2020